Failure of normalization of CA19-9 following resection for pancreatic cancer is tantamount to metastatic disease
Background Multidisciplinary therapy for pancreatic cancer involves radical resection
followed by gemcitabine-based chemotherapy. Carbohydrate antigen 19-9 (CA19-9), when …
followed by gemcitabine-based chemotherapy. Carbohydrate antigen 19-9 (CA19-9), when …
[引用][C] Failure of Normalization of CA19-9 Following Resection for Pancreatic Cancer is Tantamount to Metastatic Disease
SRZ Abdel-Misih, I Hatzaras, C Schmidt… - Annals of Surgical …, 2010 - cir.nii.ac.jp
Failure of Normalization of CA19-9 Following Resection for Pancreatic Cancer is Tantamount
to Metastatic Disease | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲ恁縖サイニィ] 詳細 …
to Metastatic Disease | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲ恁縖サイニィ] 詳細 …
Failure of Normalization of CA19-9 Following Resection for Pancreatic Cancer is Tantamount to Metastatic Disease
R Sherif, Z Abdel-misih, I Hatzaras… - Annals of Surgical …, 2011 - search.proquest.com
Multidisciplinary therapy for pancreatic cancer involves radical resection followed by
gemcitabine-based chemotherapy. Carbohydrate antigen 19-9 (CA19-9), when elevated …
gemcitabine-based chemotherapy. Carbohydrate antigen 19-9 (CA19-9), when elevated …
Failure of normalization of CA19-9 following resection for pancreatic cancer is tantamount to metastatic disease
SRZ Abdel-Misih, I Hatzaras… - Annals of surgical …, 2011 - pubmed.ncbi.nlm.nih.gov
Background Multidisciplinary therapy for pancreatic cancer involves radical resection
followed by gemcitabine-based chemotherapy. Carbohydrate antigen 19-9 (CA19-9), when …
followed by gemcitabine-based chemotherapy. Carbohydrate antigen 19-9 (CA19-9), when …
[HTML][HTML] Failure of Normalization of CA19-9 Following Resection for Pancreatic Cancer is Tantamount to Metastatic Disease
SRZ Abdel-Misih, I Hatzaras, C Schmidt… - Annals of surgical …, 2011 - ncbi.nlm.nih.gov
Background Multidisciplinary therapy for pancreatic cancer involves radical resection
followed by gemcitabine-based chemotherapy. Carbohydrate antigen 19-9 (CA19-9), when …
followed by gemcitabine-based chemotherapy. Carbohydrate antigen 19-9 (CA19-9), when …
[PDF][PDF] Failure of Normalization of CA19-9 Following Resection for Pancreatic Cancer is Tantamount to Metastatic Disease
SRZ Abdel-Misih, MD Saab, CNP Dori Klemanski… - Ann Surg …, 2011 - academia.edu
Background—Multidisciplinary therapy for pancreatic cancer involves radical resection
followed by gemcitabine-based chemotherapy. Carbohydrate antigen 19-9 (CA19-9), when …
followed by gemcitabine-based chemotherapy. Carbohydrate antigen 19-9 (CA19-9), when …
Failure of normalization of CA19-9 following resection for pancreatic cancer is tantamount to metastatic disease.
SR Abdel-Misih, I Hatzaras, C Schmidt… - Annals of Surgical …, 2010 - europepmc.org
Background Multidisciplinary therapy for pancreatic cancer involves radical resection
followed by gemcitabine-based chemotherapy. Carbohydrate antigen 19-9 (CA19-9), when …
followed by gemcitabine-based chemotherapy. Carbohydrate antigen 19-9 (CA19-9), when …
Failure of normalization of CA19-9 following resection for pancreatic cancer is tantamount to metastatic disease
SRZ Abdel-Misih, I Hatzaras… - Annals of Surgical …, 2011 - ohiostate.elsevierpure.com
Background: Multidisciplinary therapy for pancreatic cancer involves radical resection
followed by gemcitabinebased chemotherapy. Carbohydrate antigen 19-9 (CA19-9), when …
followed by gemcitabinebased chemotherapy. Carbohydrate antigen 19-9 (CA19-9), when …
Failure of normalization of CA19-9 following resection for pancreatic cancer is tantamount to metastatic disease
SRZ Abdel-Misih, I Hatzaras… - Annals of Surgical …, 2011 - einstein.elsevierpure.com
Background: Multidisciplinary therapy for pancreatic cancer involves radical resection
followed by gemcitabinebased chemotherapy. Carbohydrate antigen 19-9 (CA19-9), when …
followed by gemcitabinebased chemotherapy. Carbohydrate antigen 19-9 (CA19-9), when …
[PDF][PDF] Failure of Normalization of CA19-9 Following Resection for Pancreatic Cancer is Tantamount to Metastatic Disease
SRZ Abdel-Misih, MD Saab, CNP Dori Klemanski… - Ann Surg …, 2011 - researchgate.net
Background—Multidisciplinary therapy for pancreatic cancer involves radical resection
followed by gemcitabine-based chemotherapy. Carbohydrate antigen 19-9 (CA19-9), when …
followed by gemcitabine-based chemotherapy. Carbohydrate antigen 19-9 (CA19-9), when …